Zacks Research Brokers Decrease Earnings Estimates for MTD

Mettler-Toledo International Inc. (NYSE:MTD - Free Report) - Equities researchers at Zacks Research decreased their Q1 2025 EPS estimates for Mettler-Toledo International in a research report issued to clients and investors on Monday, January 6th. Zacks Research analyst R. Department now expects that the medical instruments supplier will earn $8.42 per share for the quarter, down from their previous estimate of $8.78. The consensus estimate for Mettler-Toledo International's current full-year earnings is $40.42 per share. Zacks Research also issued estimates for Mettler-Toledo International's Q2 2025 earnings at $10.25 EPS, FY2025 earnings at $41.94 EPS, Q1 2026 earnings at $9.97 EPS, Q2 2026 earnings at $11.03 EPS and FY2026 earnings at $48.62 EPS.

A number of other analysts have also recently commented on the stock. Robert W. Baird cut their price target on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a "neutral" rating for the company in a research note on Monday, November 11th. Wells Fargo & Company reduced their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an "equal weight" rating for the company in a report on Monday, November 11th. Citigroup upgraded Mettler-Toledo International from a "sell" rating to a "neutral" rating and upped their price objective for the company from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. Evercore ISI upgraded Mettler-Toledo International from an "in-line" rating to an "outperform" rating and lifted their target price for the stock from $1,375.00 to $1,450.00 in a research note on Thursday, January 2nd. Finally, Stifel Nicolaus dropped their price target on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a "buy" rating on the stock in a research note on Monday, November 11th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $1,351.25.

Mettler-Toledo International Trading Down 0.8 %

Shares of NYSE:MTD traded down $9.54 during trading on Wednesday, hitting $1,245.45. 109,332 shares of the company were exchanged, compared to its average volume of 111,746. Mettler-Toledo International has a fifty-two week low of $1,122.21 and a fifty-two week high of $1,546.93. The stock has a market cap of $26.28 billion, a price-to-earnings ratio of 33.58, a P/E/G ratio of 4.21 and a beta of 1.12. The firm has a fifty day moving average price of $1,255.29 and a two-hundred day moving average price of $1,351.53.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, beating the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The company had revenue of $954.54 million during the quarter, compared to analysts' expectations of $941.93 million.

Insiders Place Their Bets

In other Mettler-Toledo International news, Director Elisha W. Finney sold 76 shares of the firm's stock in a transaction on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the transaction, the director now owns 240 shares in the company, valued at $314,820. This trade represents a 24.05 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Gerry Keller sold 140 shares of Mettler-Toledo International stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total value of $175,572.60. Following the completion of the transaction, the insider now directly owns 6 shares of the company's stock, valued at $7,524.54. This represents a 95.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.94% of the company's stock.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the stock. Blue Trust Inc. raised its holdings in shares of Mettler-Toledo International by 242.9% during the 3rd quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier's stock worth $34,000 after buying an additional 17 shares in the last quarter. Ashton Thomas Securities LLC acquired a new position in shares of Mettler-Toledo International during the third quarter worth $37,000. Itau Unibanco Holding S.A. acquired a new position in Mettler-Toledo International in the 2nd quarter worth about $42,000. Raleigh Capital Management Inc. raised its position in Mettler-Toledo International by 272.7% in the third quarter. Raleigh Capital Management Inc. now owns 41 shares of the medical instruments supplier's stock valued at $61,000 after purchasing an additional 30 shares during the last quarter. Finally, Whittier Trust Co. of Nevada Inc. boosted its stake in shares of Mettler-Toledo International by 60.0% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 48 shares of the medical instruments supplier's stock valued at $72,000 after purchasing an additional 18 shares in the last quarter. Institutional investors own 95.07% of the company's stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.